ReviewPharmacoEconomics2016
Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic Evidence.
Alexis Llewellyn et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewPharmacoEconomics2016
Alexis Llewellyn et al.PubMed ↗Publisher ↗
No numbers read from the abstract.